<DOC>
	<DOCNO>NCT00252226</DOCNO>
	<brief_summary>This single center , open prospective study evaluate effectiveness quetiapine monotherapy maintenance treatment adolescent patient bipolar spectrum disorder ( bipolar I bipolar II disorder , cyclothymia , bipolar disorder otherwise specify [ bipolar NOS ] ) minimum 48 week . Patients screen ( enrolment phase ) either already stabilize acute episode mania/hypomania depression .</brief_summary>
	<brief_title>Quetiapine ( Seroquel ) Maintenance Treatment Early Onset Bipolar Spectrum Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Provide write informed consent initiation studyrelated procedure . 2 . A lifetime diagnosis bipolar spectrum disorder : bipolar I bipolar II disorder , cyclothymia , bipolar NOS , define Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) . 3 . Male female , age 12 20 year enrolment . 4 . No preventive treatment least one month prior enrolment . 5 . Female patient childbearing potential sexually active must use reliable method contraception . Reliable method contraception include hormonal contraceptive ( e.g. , oral contraceptive longterm injectable implantable hormonal contraceptive ) , doublebarrier method ( e.g. , condom diaphragm , condom foam , condom sponge ) , intrauterine device , tubal ligation . 6 . Able understand comply requirement study . 1 . Known intolerance lack response quetiapine fumarate judge investigator . 2 . Pregnancy lactation . Female patient childbearing potential must negative urine human chorionic gonadotropin ( HCG ) test enrolment . 3 . History substance alcohol dependence within three month enrolment ( except caffeine nicotine dependence ) , define DSMIV criterion . 4 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment . 5 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , saquinavir . Should new drug start , investigator consult pharmacy list exhaustive . 6 . Use follow cytochrome P450 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . 7 . Current use fluvoxamine , nefazodone , grapefruit juice . 8 . Thyroid stimulate hormone ( TSH ) concentration outside normal range . 9 . Unstable inadequately treat medical illness ( e.g. , diabetes , angina pectoris , hypertension ) judge investigator . 10 . History hepatic disease , elevate hepatic enzyme entry test . 11 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment . 12 . Use experimental drug within 30 day enrolment . 13 . Previous trial maintenance therapy .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Quetiapine</keyword>
	<keyword>bipolar spectrum disorder</keyword>
</DOC>